Showing 5551-5560 of 20461 results for "".
- Natera’s Signatera Data: Advancements in Lung Cancer Profilinghttps://reachmd.com/news/nateras-signatera-data-advancements-in-lung-cancer-profiling/2483102/As lung cancer continues to rank as the most commonly diagnosed cancer worldwide, the push for more precise, personalized diagnostics remains urgent. In that context, Natera, Inc.—a leader in cell-free DNA technology and precision medicine—
- Nutritional and Biochemical Pathways in Vision Health: The Role of Omega-3 Fatty Acids and Lipid Metabolismhttps://reachmd.com/news/nutritional-and-biochemical-pathways-in-vision-health-the-role-of-omega-3-fatty-acids-and-lipid-metabolism/2483110/In the dynamic field of eye health, the intersection of nutrition and biochemical processes presents both challenges and opportunities for preserving vision. Clinicians are increasingly emphasizing the pivotal role that dietary components, such as omega-3 fatty acids, play in supporting ocu
- Exploring Degradation and Metabolic Effects in Modern Pharmacotherapyhttps://reachmd.com/news/exploring-degradation-and-metabolic-effects-in-modern-pharmacotherapy/2483113/As pharmacotherapy evolves, addressing the clinical challenge of assessing treatment stability and systemic impact becomes increasingly crucial. Biosimilars, pivotal in modern treatment strategies, are continually scrutinized under thermal stress, influencing therapeutic approaches
- Amarte Relaunches Dermatologist-Formulated Ultra Veil Daily SPF 40https://reachmd.com/news/amarte-relaunches-dermatologist-formulated-ultra-veil-daily-spf-40/2483103/Amarte Skin Care has relaunched its flagship sunscreen, ULTRA VEIL® DAILY SPF 40, according to a press release from the manufacturer. The updated product maintains its position as a top-tier hybrid sunscreen, the press release
- Enliven Therapeutics' Pioneering SOHO 2025 Presentations: New Frontiers in Hematologyhttps://reachmd.com/news/enliven-therapeutics-pioneering-soho-2025-presentations-new-frontiers-in-hematology/2483101/With early findings from the ENABLE Phase 1a/1b trial presented at SOHO 2025, Enliven Therapeutics reports preliminary signals that may help address treatment resistance in chronic myeloid leukemia. Enliven Therapeutics' early-stage investigation unfolds as the ENABLE Phase 1a/1b tri
- Deciphering Subaortic Stenosis: Navigating Diagnostic Challenges and Anatomical Complexitieshttps://reachmd.com/news/deciphering-subaortic-stenosis-navigating-diagnostic-challenges-and-anatomical-complexities/2483080/Subaortic stenosis, an often under-recognized cause of narrowing below the aortic valve (left ventricular outflow tract), poses significant diagnostic challenges due to its diverse anatomical variations. Clinicians should employ precise cardiac imaging to guide diagnosis and intervention de
- Prognostic and Therapeutic Biomarkers in Cancer: A Pathway to Personalized Treatmenthttps://reachmd.com/news/prognostic-and-therapeutic-biomarkers-in-cancer-a-pathway-to-personalized-treatment/2483084/Clinicians are weighing the promise of biomarker-driven precision against the practical realities of integrating these signals into everyday care. Amid the push to translate laboratory signals into care, the integration of immune–metabolic models into hepatocellular
- Breaking New Ground: Novartis’ Monoclonal Antibody for Sjögren’s Syndromehttps://reachmd.com/news/breaking-new-ground-novartis-monoclonal-antibody-for-sjogrens-syndrome/2483100/Novartis’ groundbreaking monoclonal antibody is reshaping the discussion around Sjögren’s syndrome treatment by targeting core immunologic drivers while new clinical data emerge.
- The Potential Role of Omega-3 Fatty Acids in Preventing Nearsightedness in Childrenhttps://reachmd.com/news/the-potential-role-of-omega-3-fatty-acids-in-preventing-nearsightedness-in-children/2483098/Nearsightedness continues its global rise in children, prompting researchers to explore whether omega-3 fatty acids could play a supportive role. The prevalence of nearsightedness, also known as myopia, in children is climbing worldwide, signaling a pressing need for effective preven
- Advancements in Liver Transplant Anesthesia: Enhanced Recovery Protocolshttps://reachmd.com/news/advancements-in-liver-transplant-anesthesia-enhanced-recovery-protocols/2483092/Liver transplant procedures are currently witnessing a transformation driven by enhanced recovery protocols in anesthesia. Many centers are adapting ERAS-style perioperative pathways for liver transplantation, aligned with emerging consensus statements, though implementation remains center-